Metallothionein (MT) is a low molecular weight protein with anti-apoptotic properties that has been demonstrated to scavenge free radicals in vitro. MT has not been extensively investigated within the context of aging biology. The purpose of this review, therefore, is to discuss findings on MT that are relevant to basic aging mechanisms and to draw attention to the possible role of MT in pro-longevity interventions. MT is one of just a handful of proteins that, when overexpressed, has been demonstrated to increase mouse lifespan. MT also protects against development of obesity in mice provided a high fat diet as well as diet-induced oxidative stress damage. Abundance of MT is responsive to caloric restriction (CR) and inhibition of the insulin/insulin-like signaling (IIS) pathway, and elevated MT gene expression has been observed in tissues from fasted and CR-fed mice, long-lived dwarf mice, worms maintained under CR conditions, and long-lived daf-2 mutant worms. The dysregulation of MT in these systems is likely to have tissue-specific effects on aging outcomes. Further investigation will therefore be needed to understand how MT contributes to the response of invertebrates and mice to CR and the endocrine mutations studied by aging researchers.
Introduction
Caloric restriction (CR) and the inhibition of insulin/insulin-like signals (IIS) have been widely investigated as interventions that delay the onset of age-related disease while promoting an overall increase in both average and maximum lifespan. Understanding the cellular, metabolic and physiological effects of these interventions could point towards clinical tools that foster development of healthy aging patterns in human populations. Additionally, as interventions that affect age-associated diseases in multiple organs, understanding the downstream effects of CR and IIS may provide insights into "mechanisms of aging". Despite extensive investigation, however, there is no firm consensus on why favorable aging outcomes result from either CR or genetic inhibition of IIS (Berryman et al., 2008; Ladiges et al., 2009; Avogaro et al., 2010) . One influential idea is that these interventions trigger a type of cell defense response, leading to a cellular phenotype characterized by resistance to multiple forms of stress and the damage associated with normal aging (Masoro and Austad, 1996; Gems and Partridge, 2008; Masoro, 2005; Rattan, 2006) . In this view, CR and IIS inhibition induce a "hormesis" response, which could explain some salubrious effects of these interventions (Masoro and Austad, 1996; Masoro, 2005; Rattan, 2006; Gems and Partridge, 2008 lar, is activation of anti-oxidant defenses, and a number of studies have indeed shown that CR or IIS inhibition can reduce free radical damage (Honda and Honda, 1999; Baumeister et al., 2006; Papaconstantinou, 2009; Opalach et al., 2010) . Collectively, these ideas have fueled investigation of stress-sensitive pathways and proteins as potential downstream mediators of CR and/or loss of IIS, including heat shock proteins (HSPs), superoxide dismutase (SOD), sirtuins, and stress-regulated polyphenol compounds derived from plants (e.g., resveratrol). At present, however, the most convincing evidence on behalf of these stress-sensitive pathways has been collected from invertebrate systems, and there has been little to suggest that specific activation of a stress-sensitive pathway can generate a long-lived mouse. Worse still, for some of the abovementioned pathways and proteins, specific activation appears to decrease mouse lifespan, rather than to increase it (Vanhooren et al., 2008) .
Metallothionein (MT) is a versatile low molecular weight (7 kDa) protein that participates in the cellular response to numerous forms of stress. In particular, in vitro evidence has suggested that MT can serve as a scavenger of free radicals (Thornalley and Vasák, 1985) , which are viewed as a driving force behind multiple ageassociated pathologies (Harman, 1956) , as well as a target in the hormesis response associated with CR and/or IIS inhibition. Relative to other stress-sensitive proteins and pathways (e.g., HSPs, SOD and sirtuins), MT has not been aggressively evaluated within the context of aging biology and the study of basic aging mechanisms. Reviews covering potential downstream mechanisms of CR and/or IIS inhibition, for example, have not commonly discussed MT
